174 related articles for article (PubMed ID: 7052342)
1. Antagonism of 5-hydroxytryptamine receptors by quipazine.
Lansdown MJ; Nash HL; Preston PR; Wallis DI; Williams RG
Br J Pharmacol; 1980 Mar; 68(3):525-32. PubMed ID: 7052342
[TBL] [Abstract][Full Text] [Related]
2. Effects of divalent cations on responses of a sympathetic ganglion to 5-hydroxytryptamine and 1,1-dimethyl-4-phenyl piperazinium.
Nash HL; Wallis DI
Br J Pharmacol; 1981 Jul; 73(3):759-72. PubMed ID: 6265020
[TBL] [Abstract][Full Text] [Related]
3. Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonists.
Round A; Wallis DI
Neuropharmacology; 1987 Jan; 26(1):39-48. PubMed ID: 3561718
[TBL] [Abstract][Full Text] [Related]
4. Depolarizing responses recorded from nodose ganglion cells of the rabbit evoked by 5-hydroxytryptamine and other substances.
Wallis DI; Stansfeld CE; Nash HL
Neuropharmacology; 1982 Jan; 21(1):31-40. PubMed ID: 7063107
[TBL] [Abstract][Full Text] [Related]
5. 5-HT antagonists and blockade of neuronal (5-HT) receptors on ganglion cells.
Nash HL; Wallis DI; Ash G
Gen Pharmacol; 1984; 15(4):339-44. PubMed ID: 6149168
[TBL] [Abstract][Full Text] [Related]
6. Responses to 5-hydroxytryptamine evoked in the hemisected spinal cord of the neonate rat.
Connell LA; Wallis DI
Br J Pharmacol; 1988 Aug; 94(4):1101-14. PubMed ID: 3207976
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine depolarizes neonatal rat motorneurones through a receptor unrelated to an identified binding site.
Connell LA; Wallis DI
Neuropharmacology; 1989 Jun; 28(6):625-34. PubMed ID: 2755565
[TBL] [Abstract][Full Text] [Related]
8. The depolarizing action of 5-hydroxytryptamine on rabbit vagal primary afferent and sympathetic neurones and its selective blockade by MDL 72222.
Azami J; Fozard JR; Round AA; Wallis DI
Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):423-9. PubMed ID: 3990828
[TBL] [Abstract][Full Text] [Related]
9. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
Green AR; Hall JE; Rees AR
Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
[TBL] [Abstract][Full Text] [Related]
10. Further studies on the action of 5-hydroxytryptamine on lumbar motoneurones in the rat isolated spinal cord.
Wallis DI; Connell LA; Kvaltinova Z
Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):344-52. PubMed ID: 1906582
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.
Eglen RM; Swank SR; Walsh LK; Whiting RL
Br J Pharmacol; 1990 Nov; 101(3):513-20. PubMed ID: 2076474
[TBL] [Abstract][Full Text] [Related]
12. 2-(2-Aminoethyl)-quinoline (D-1997): a novel agonist at 5-hydroxytryptamine1-like receptors in the canine basilar artery.
Terrón JA; López-Muñoz FJ; Hong E; Villalón CM
Arch Int Pharmacodyn Ther; 1994; 327(1):56-68. PubMed ID: 7944828
[TBL] [Abstract][Full Text] [Related]
13. Membrane potential changes induced by 5-hydroxytryptamine in the rabbit superior cervical ganglion.
Wallis DI; Woodward B
Br J Pharmacol; 1975 Oct; 55(2):199-212. PubMed ID: 1201378
[TBL] [Abstract][Full Text] [Related]
14. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.
Hewson G; Leighton GE; Hill RG; Hughes J
Br J Pharmacol; 1988 Oct; 95(2):598-604. PubMed ID: 2906561
[TBL] [Abstract][Full Text] [Related]
15. A comparison of fast and slow depolarizations evoked by 5-HT in guinea-pig coeliac ganglion cells in vitro.
Wallis DI; Dun NJ
Br J Pharmacol; 1988 Jan; 93(1):110-20. PubMed ID: 3349227
[TBL] [Abstract][Full Text] [Related]
16. The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.
Downie DL; Hope AG; Belelli D; Lambert JJ; Peters JA; Bentley KR; Steward LJ; Chen CY; Barnes NM
Br J Pharmacol; 1995 Apr; 114(8):1641-51. PubMed ID: 7541281
[TBL] [Abstract][Full Text] [Related]
17. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a presynaptic inhibitory action of 5-hydroxytryptamine in a mammalian sympathetic ganglion.
Dun NJ; Karczmar AG
J Pharmacol Exp Ther; 1981 Jun; 217(3):714-8. PubMed ID: 6112264
[TBL] [Abstract][Full Text] [Related]
19. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.
Barnes JM; Barnes NM; Costall B; Jagger SM; Naylor RJ; Robertson DW; Roe SY
Br J Pharmacol; 1992 Feb; 105(2):500-4. PubMed ID: 1559139
[TBL] [Abstract][Full Text] [Related]
20. Selective antagonism of the GABA(A) receptor by ciprofloxacin and biphenylacetic acid.
Green MA; Halliwell RF
Br J Pharmacol; 1997 Oct; 122(3):584-90. PubMed ID: 9351519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
